Springfield Drug Company Pays $110,00 Federal Civil Penalty, Reports U.S. Attorney

Apr 10, 2001, 01:00 ET from U.S. Attorney

    SPRINGFIELD, Mass., April 10 /PRNewswire/ -- United States Attorney Donald
 K. Stern today announced that AMERI

SOURCE CORPORATION has paid $110,000 to settle federal civil claims that it violated the Comprehensive Drug Abuse Prevention and Control Act of 1970 (the "Act"). The Act requires pharmacists, manufacturers and wholesalers to keep careful records and reports to ensure that controlled substances are not diverted to illegal use. AMERI

SOURCE CORPORATION operates a distribution facility at 570 Cottage Street in Springfield. The settlement arises out of an investigation into excessive orders of pseudoephedrine. The United States alleged that AMERI

SOURCE failed to report at least thirty excessive orders of pseudoephedrine between December 1998 and May 1999. Pseudoephedrine is a listed chemical involved in the manufacture of methamphetamine. Federal law requires pharmaceutical companies to report excessive orders to the U.S. Drug Enforcement Administration. This case was investigated by the U.S. Drug Enforcement Administration and prosecuted by Assistant U.S. Attorney Karen L. Goodwin in Stern's Springfield office.

SOURCE U.S. Attorney
    SPRINGFIELD, Mass., April 10 /PRNewswire/ -- United States Attorney Donald
 K. Stern today announced that AMERISOURCE CORPORATION has paid $110,000 to
 settle federal civil claims that it violated the Comprehensive Drug Abuse
 Prevention and Control Act of 1970 (the "Act").  The Act requires pharmacists,
 manufacturers and wholesalers to keep careful records and reports to ensure
 that controlled substances are not diverted to illegal use.  AMERISOURCE
 CORPORATION operates a distribution facility at 570 Cottage Street in
 Springfield.
     The settlement arises out of an investigation into excessive orders of
 pseudoephedrine.  The United States alleged that AMERISOURCE failed to report
 at least thirty excessive orders of pseudoephedrine between December 1998 and
 May 1999.  Pseudoephedrine is a listed chemical involved in the manufacture of
 methamphetamine.  Federal law requires pharmaceutical companies to report
 excessive orders to the U.S. Drug Enforcement Administration.
     This case was investigated by the U.S. Drug Enforcement Administration and
 prosecuted by Assistant U.S. Attorney Karen L. Goodwin in Stern's Springfield
 office.
 
 SOURCE  U.S. Attorney